Clinical trial
Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of…
NCT00483457 · Vanderbilt-Ingram Cancer Center, Other · Completed
Key facts
| NCT number | NCT00483457 |
|---|---|
| Title | Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients |
| Official title | Pilot Study of the Effects of Epidermal Growth Factor Receptor (EGFR) Inhibitors on the EGFR in Skin Lesions |
| Lead sponsor | Vanderbilt-Ingram Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Solid Tumor |
| Intervention type | Drug, Genetic, Other, Procedure |
| Interventions | enzyme inhibitor therapy, protein expression analysis, immunohistochemistry staining method, laboratory biomarker analysis, biopsy |
| Enrollment | 33 |
| Start date | Feb 1, 2006 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Jun 7, 2007 |
| Last update posted | Sep 3, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: